Why the study?
Does glucose-stimulated insulin secretion suppress hepatic triglyceride and apoB production in fasted rats?
Does glucose-stimulated insulin secretion suppress hepatic triglyceride and apoB production in fasted rats?
Glucose-stimulated insulin secretion suppresses hepatic VLDL triglyceride and apoB production in vivo, highlighting insulin's regulatory role in postprandial lipid metabolism.
Answers are grounded in this paper and cite their sources.
Highlights insulin's role in rodent VLDL regulation; leaves open translation to human postprandial lipid metabolism.
The current study assessed in vivo the effect of insulin on triglyceride-rich lipoprotein (TRL) production by rat liver. Hepatic triglyceride and apolipoprotein B (apoB) production were measured in anesthetized, fasted rats injected intravenously with Triton WR-1339 (400 mg/kg). After intravascular catabolism was blocked by detergent treatment, glucose (500 mg/kg) was injected to elicit insulin secretion, and serum triglyceride and apoB accumulation were monitored over the next 3 h. In glucose-injected rats, triglyceride secretion averaged 22.5 +/- 2.1 microg.ml(-1).min(-1), which was significantly less by 30% than that observed in saline-injected rats, which averaged 32.1 +/- 1.4 microg.ml(-1).min(-1). ApoB secretion was also significantly reduced by 66% in glucose-injected rats. ApoB immunoblotting indicated that both B100 and B48 production were significantly reduced after glucose injection. Results support the conclusion that insulin acts in vivo to suppress hepatic very low density lipoprotein (VLDL) triglyceride and apoB secretion and strengthen the concept of a regulatory role for insulin in VLDL metabolism postprandially.
No takes yet. Share an insight, caveat, or question.
Chirieac et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: